New Therapeutics Forum

A number of companies based on the Science Park have employees who are members of the New Therapeutics Forum and they are welcome to attend the next meeting. It is open to all scientists researching new therapeutics in Cambridge and the local area.

The purpose of the CamNTF is to promote interacBons between scienBsts from academia & industry in order to improve opportunities for biotechnology research and development. Meeting attendance is free but all attendees must register in advance. Spaces are limited, so early registration is encouraged to avoid disappointment.

Programme:

17:30 – Registratioon, tea and coffee

18:00 – Dr Stefan Platz, Global Head, Drug Safety and Metabolism, AstraZeneca: Welcome and overview of the Cambridge Alliance on Medicines Safety (CAMS) 1

18:10 – Dr Chris Powell, VP TranslaBonal Medicine & ComparaBve Pathobiology, GlaxoSmithKline: Medicines Safety: Past, Present and Future Challenges

18:40 – Dr Ania Wilczynska, InvesBgator ScienBst, MRC Toxicology Unit: Control of transla1on as a central aspect of mRNA therapeutic safety

18:55 – Dr Andreas Bender, Reader for Molecular Informatics, Centre for Molecular Informatics, Department of Chemistry, University of Cambridge: Using Compound Profiling Data to Understand and An1cipate Adverse Drug Reactions

19:10 – Networking and Refreshments

20:00 – Meeting Close